Merck

MERCK NEWSROOM (5 press releases)

Advanced Filtering & Sorting Options:

European Medicines Agency starts review of Tredaptive, Pelzont and Trevaclyn

PRESS RELEASE -- 27, December 2012

Agency issues interim advice 27-12-2012 — /europawire.eu/ — The European Medicines Agency has started a review of the safety and efficacy of Tredaptive, Pelzont and Trevaclyn, identical medicines that are used to treat adults with dyslipidaemia (abnormally high levels of fat … Read the full press release

QIAGEN gains SFDA approval to market careHPV Test in China – expanding access to HPV testing in low-resource countries

PRESS RELEASE -- 6, December 2012

Commercial launch of careHPV in China and other emerging markets will enable high-quality screening for prevention of cervical cancer “Country of Origin” approval key for dissemination, other countries are able to use this as a basis for registration care HPV is the first HPV test designed … Read the full press release

Merck Sharp and Dohme Ltd. withdraws its marketing-authorisation application for Jenzyl (ridaforolimus)

PRESS RELEASE -- 4, December 2012

4-12-2012 — /europawire.eu/ — The European Medicines Agency has been formally notified by Merck Sharp and Dohme Ltd. of its decision to withdraw its application for a centralised marketing authorisation for the medicine Jenzyl (ridaforolimus), 10-mg tablets. Jenzyl was intended to … Read the full press release

Langjährige Betriebszugehörigkeit: 2395 Arbeitsjahre: Jubilare feiern im Mercedes-Benz Werk Rastatt

PRESS RELEASE -- 15, November 2012

– Werkleitung und Betriebsrat betonen Beitrag der 91 Jubilare zum Unternehmenserfolg – Oberbürgermeister Hans Jürgen Pütsch überreicht Ehrenurkunden des Landes Baden-Württemberg 15-11-2012 — /europawire.eu/ —  91 Mitarbeiterinnen und Mitarbeiter begehen dieses Jahr im Mercedes-Benz Werk Rastatt ihre Arbeitsjubiläen. „Im Sommer haben … Read the full press release

Merck Serono and Auxogyn Announce Collaboration on Eeva™ Test

PRESS RELEASE -- 29, October 2012

• The Early Embryo Viability Assessment (Eeva) Test is designed to provide data that will help assess embryo viability • Strategic partnership demonstrates Merck Serono’s commitment to investing in assisted reproductive technologies Geneva, Switzerland, and Menlo Park, Calif., USA, 29-10-2012 — /europawire.eu/ — Merck Serono, a … Read the full press release